权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Testing Effective Methods to Recruit Sexual and Gender Minority Cancer Patients for Cancer Studies

测试招募性少数癌症患者进行癌症研究的有效方法

基本信息

批准号：
10515913
负责人：
B R Simon Rosser
金额：
$ 67.99万
依托单位：
UNIVERSITY OF MINNESOTA
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-08-12 至 2027-07-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10515913
关键词：
Accounting Address Advertising Affect Alcohol abuse Area Attitude Belief Bisexual Cancer Burden Cancer Patient Cancer Survivor Caring Clinic Clinic Visits Comparative Study Computerized Medical Record Conceptions Cybersex Data Data Sources Development Discrimination Ethnic Origin Exclusion Face Female Gays Gender Gender Identity HIV Heterosexuals Intervention Trial Interview Lesbian Gay Bisexual Transgender Literature Malignant Neoplasms Malignant neoplasm of prostate Measures Mental Health Methodology Methods Minority Health Research Patient Recruitments Patients Performance Persons Population Primary Prevention Professional Organizations Protocols documentation Race Rehabilitation therapy Reporting Research Research Personnel Sampling Second Primary Cancers Sex Orientation Sexual and Gender Minorities Shapes Site Smoking Social support Structure Subgroup Surveys Survivors Telephone Testing Time Treatment outcome Underserved Population United States National Institutes of Health Woman Work Workload advanced disease anticancer research base cancer care cancer health disparity cancer risk cancer therapy cancer type care delivery cis-female cis-male cisgender comparison group cost design effectiveness testing evidence base experience gender minority gender minority group health disparity informant intersectionality male men minority stress neglect novel patient population patient stratification perceived discrimination prevent recruit research study satisfaction sex sexual minority sexual minority men sexual minority women social social stigma sociodemographics success theories transgender willingness

项目摘要

Abstract Recently, NCI called for research to effectively study small or rare populations relevant to cancer research. Sexual and gender minorities (SGM) are small populations at disproportionate risk for cancer but who have been under-researched in cancer studies. The principal challenge common across lesbian, gay, bisexual, and transgender populations is to develop effective methods to identify and recruit patients and survivors who are SGM into NCI cancer studies. Two technical advances have transformative potential to advance research on health disparities in SGM cancer patients. First, online recruitment has yielded large SGM samples in other areas of research (e.g., HIV primary prevention), but using online methods to recruit SGM cancer patients has not been rigorously studied. Second, cancer clinics have begun to include sexual orientation and gender identity (SOGI) data in the electronic medical record, but we need to test protocols on how to recruit SGM cancer patients using this data source. This application is based upon our recent success in overcoming challenges to recruit over 400 gay and bisexual prostate cancer patients into an R01 intervention trial of tailored rehabilitation for this population. We will replicate and expand upon these clinic-based and online methods to study how to recruit three small SGM populations – (1) sexual minority cisgender men, (2) sexual minority cisgender women, and (3) transgender and gender non-binary cancer patients - into cancer research studies. We have three specific aims. In Aim 1, we will document, in depth, SGM’s attitudes towards participating in NIH cancer research, identifying the facilitators and barriers that each group reports influences their willingness to participate. We will also investigate any impact poor cancer care and discrimination has on research participation. We will investigate these in cisgender SM men, cisgender SM women and gender minority cancer patients (n=15 per group) and compare experiences within these small populations and between SGM and a cisgender, heterosexual patient comparison group. In Aim 2, we will test the effectiveness, efficiency, cost, and workload in using two clinic SOGI-based strategies and three online strategies to recruit SGM small populations (150 each) compared to recruiting a sample of cisgender, heterosexual cancer patients. We predict size of the small population will negatively correlate with work, cost, and time involved, but positively correlate with yield. In Aim 3, we will conduct an online quantitative survey of willingness to participate in cancer research with 450 SGM cancer patients (150 per group) versus a cisgender heterosexual group (150 men and 150 women). Key measures assess facilitators and barriers to participation in NIH cancer research. To advance measures, we will assess performance of each group on five validated cancer scales to compare cancer care experience, discrimination in treatment, and outcomes. Finally, we will integrate and triangulate findings and assess intersectionality with race/ethnicity. This study will establish what recruitment strategies are effective across SGM populations, and which may be specific to each subgroup.

抽象的最近，NCI 呼吁开展有效研究与癌症研究相关的小规模或稀有人群的研究。性少数群体 (SGM) 是指患癌症风险不成比例但患有癌症的少数群体在癌症研究中尚未得到充分研究。女同性恋、男同性恋、双性恋和跨性别者普遍面临的主要挑战跨性别人群的目标是制定有效的方法来识别和招募患有以下疾病的患者和幸存者 SGM 参与 NCI 癌症研究。两项技术进步具有推动研究的变革潜力 SGM 癌症患者的健康差异。首先，线上招聘在其他领域已产生大量SGM样本研究领域（例如艾滋病毒初级预防），但使用在线方法招募 SGM 癌症患者没有经过严格的研究。二、癌症诊所开始纳入性取向和性别电子病历中的身份（SOGI）数据，但我们需要测试如何招募 SGM 的协议使用此数据源的癌症患者。该应用程序基于我们最近成功克服的招募 400 多名同性恋和双性恋前列腺癌患者参加 R01 干预试验的挑战为该人群量身定制康复治疗。我们将复制并扩展这些基于诊所和在线的研究如何招募三个小型 SGM 人群的方法 – (1) 性少数顺性别男性，(2) 性少数少数顺性别女性，以及 (3) 跨性别者和非二元性别癌症患者 - 参与癌症研究研究。我们有三个具体目标。在目标1中，我们将深入记录SGM对于参与 NIH 癌症研究，确定每个小组报告影响的促进因素和障碍他们的参与意愿。我们还将调查不良的癌症护理和歧视对研究参与。我们将调查顺性别 SM 男性、顺性别 SM 女性和性别少数癌症患者（每组 n=15）并比较这些小群体的经验 SGM 与顺性别、异性恋患者对照组之间的比较。在目标 2 中，我们将测试使用两种基于 SOGI 的诊所策略和三种在线策略的有效性、效率、成本和工作量与招募顺性别样本相比，招募 SGM 小群体（每个 150 人）的策略，异性恋癌症患者。我们预测，少数人口的规模将与工作、成本、和所涉及的时间，但与产量呈正相关。在目标3中，我们将进行在线定量调查愿意参与 450 名 SGM 癌症患者（每组 150 名）与顺性别患者的癌症研究异性恋组（150 名男性和 150 名女性）。关键措施评估参与的促进因素和障碍在 NIH 癌症研究中。为了推进措施，我们将评估每个小组在五个经过验证的方面的表现癌症量表可比较癌症护理经验、治疗中的歧视和结果。最后，我们将整合和三角测量研究结果并评估与种族/民族的交叉性。这项研究将确定什么招募策略在 SGM 人群中有效，并且可能针对每个亚组。